Wyman-Gordon Forgings continues to increase its capabilities to meet a broader spectrum of its current customers' requirements and to extend its reach into
broader markets," said PCC Chairman and CEO William C.
The
broader markets were weak on Friday," said William McKinley, President of Investing Systems.
Savient Pharmaceuticals is a biopharmaceutical company engaged in developing, manufacturing and marketing pharmaceutical products that target unmet medical needs in both niche and
broader markets.
Savient Pharmaceuticals is a specialty pharmaceutical company engaged in developing, manufacturing and marketing pharmaceutical products that address unmet medical needs in both niche and
broader markets.
is a specialty pharmaceuticals company engaged in developing, manufacturing and marketing pharmaceutical products that address unmet medical needs in both niche and
broader markets.
When the
broader markets are falling there are always isolated stocks making big gains," McKinley said.
is a specialty pharmaceuticals company and is engaged in developing, manufacturing and marketing pharmaceutical products that address unmet medical needs in both niche and
broader markets.
is an emerging specialty pharmaceuticals company and is engaged in developing, manufacturing and marketing pharmaceutical products that address unmet medical needs in both niche and
broader markets.
in which CLX holds a 31 percent equity interest, is expanding the distribution of its product lines into
broader markets around the world, beginning with new European markets.
NASDAQ:SVNTE) an emerging specialty pharmaceutical company engaged in developing, manufacturing and marketing pharmaceutical products that address unmet medical needs in niche and
broader markets, today announced the closing of the sale of its Delatestryl(R) product to Indevus Pharmaceuticals, Inc.
Savient") (NASDAQ: SVNTE), an emerging specialty pharmaceutical company engaged in developing, manufacturing and marketing pharmaceutical products that address unmet medical needs in niche and
broader markets, announced today that it has concluded with Barr Pharmaceuticals, Inc.
As we further expand our presence across
broader markets and reinforce our leadership position in Enterprise Contract Management, we require an experienced and pro-active investor relations firm to help support this mission.
